Could interferon-gamma be a therapeutic target for treating heart failure?
Authors:
- 16 April 2013
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 19 (2) , 227-236
Abstract
The cytokine interferon-gamma (IFN-γ) is the only known member of the type II family of interferons, and as such, binds to its own distinct receptor. It is important in host defense against infection, as well as adaptive immune responses. While a wide array of cytokines are known to be involved in adverse remodeling of the heart and the progression to heart failure, the role of IFN-γ is unclear. Recent evidence from clinical studies, animal models of myocarditis and hypertension, as well as isolated cell studies, provide conflicting data as to whether IFN-γ is pathological or protective in the heart. Thus, it is important to highlight these discrepant findings so that areas of future investigation can be identified to more clearly determine the precise role of IFN-γ in the heart. Accordingly, this review will (1) discuss the source of IFN-γ in the diseased heart; (2) summarize the data from animal studies; (3) discuss the effects of IFN-γ on isolated cardiac fibroblasts and cardiomyocytes; (4) identify signaling mechanisms that may be invoked by IFN-γ in the heart; and (5) present the clinical evidence supporting a role for IFN-γ in heart failure.Keywords
This publication has 68 references indexed in Scilit:
- Interferon-γ Causes Cardiac Myocyte Atrophy via Selective Degradation of Myosin Heavy Chain in a Model of Chronic MyocarditisThe American Journal of Pathology, 2012
- Cardiac Actions of Protein Kinase C IsoformsPhysiology, 2012
- In SituExpression of Regulatory Cytokines by Heart Inflammatory Cells in Chagas' Disease Patients with Heart FailureJournal of Immunology Research, 2012
- STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular diseaseCytokine & Growth Factor Reviews, 2011
- Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J miceExperimental Physiology, 2011
- Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-κBOncogene, 2010
- JAK redux: a second look at the regulation and role of JAKs in the heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Roles of phosphatidylinositol 3‐kinase and p38 mitogen‐activated protein kinase in the regulation of protein kinase C‐α activation in interferon‐γ‐stimulated macrophagesImmunology, 2009
- Protein kinase C in heart failure: a therapeutic target?Cardiovascular Research, 2008
- Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytesMicrobes and Infection, 2008